Mediating Role of OCT-Defined Vulnerable Plaque in the Association of Atherogenic Index of Plasma with Adverse Acute Coronary Syndrome Outcomes

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background : Acute coronary syndrome (ACS) remains a leading global cause of mortality. Although optical coherence tomography (OCT) provides detailed assessment of adverse-outcome-associated vulnerable plaque features, and the atherogenic index of plasma (AIP) is a novel lipid-related predictor of atherosclerotic cardiovascular disease, their interrelationship and combined prognostic value in ACS patients remain unclear. Objective: This study aims to examine the association between the atherogenic index of plasma (AIP) and OCT-defined vulnerable plaque features with clinical outcomes in patients with acute coronary syndrome (ACS). Methods: This retrospective single-center study enrolled 1,324 ACS patients undergoing OCT-guided PCI. AIP was calculated as log₁₀(TG/HDL-C). Vulnerable plaques were defined by four OCT features: thin-cap fibroatheroma (TCFA), lipid-to-cap ratio (LCR ≥0.33), macrophage infiltration, and cholesterol crystals. Primary outcome was MACEs (composite of all-cause death, cardiovascular death, unplanned revascularization, in-stent restenosis, angina rehospitalization, and heart failure rehospitalization). Multivariable Cox regression, Kaplan-Meier analysis, ROC curves, and mediation analysis were used. Results: During a median 441-day follow-up, 15.5% (206/1330) of patients experienced MACEs. Fully adjusted analyses revealed that both elevated AIP (≥0.21; HR=1.61, 95%CI:1.18–2.19) and all OCT-defined vulnerable plaque features (LCR≥0.33: HR=1.98; TCFA: HR=1.89; macrophage: HR=1.52; cholesterol crystals: HR=1.47; all P<0.05) independently predicted MACEs. Patients with high AIP plus ≥2 vulnerable plaque features had the highest MACEs risk (P<0.001). Adding AIP to a baseline model (C=0.59) improved prediction (ΔC=0.04; NRI=0.182, P=0.016), with further enhancement after incorporating plaque features (C=0.72; NRI=0.471, P<0.001). Vulnerable plaque features mediated 5.7–15.5% of AIP-associated cardiovascular risk (P<0.05). Conclusion: AIP and OCT-defined vulnerable plaque features serve as independent predictors of MACEs in ACS patients. Their combined assessment significantly enhances risk stratification. Furthermore, plaque features partially mediate AIP-associated cardiovascular risk.

Article activity feed